Jennifer Rinaldo

Jennifer Rinaldo has extensive expertise in commercial development and business strategy within the biopharmaceutical industry. Currently serving as Vice President at Intra-Cellular Therapies since November 2017, Jennifer previously held the position of Executive Director at Allergan from June 2006 to November 2017, where responsibilities included managing notable brands such as VRAYLAR, SAPHRIS, and VIIBRYD. Prior to that, Jennifer worked as a Senior Product Manager at Bristol-Myers Squibb from 1997 to 2006, contributing to the success of brands like ABILIFY and SERZONE. Jennifer Rinaldo holds both an MBA and a BS from the University at Buffalo.